119 related articles for article (PubMed ID: 3218905)
1. Role of dopamine receptors in neurological drug treatment.
Rinne UK
Ann Clin Res; 1988; 20(5):334-9. PubMed ID: 3218905
[No Abstract] [Full Text] [Related]
2. Levodopa for the treatment of Parkinson's disease.
Lewitt PA
N Engl J Med; 2008 Dec; 359(23):2468-76. PubMed ID: 19052127
[No Abstract] [Full Text] [Related]
3. [Dopamine agonists in the therapy of parkinson syndrome].
Kapfhammer HP; Rüther E
Nervenarzt; 1985 Feb; 56(2):69-81. PubMed ID: 3982566
[No Abstract] [Full Text] [Related]
4. Inhibitors of dopamine inactivating systems as antiparkinson drugs.
Youdim MB
Adv Neurol; 1990; 53():483-8. PubMed ID: 2239488
[No Abstract] [Full Text] [Related]
5. [Dopamine-receptor stimulants in the treatment of Parkinson's disease (author's transl)].
Ringwald E; Hirt D; Markstein R; Vigouret JM
Nervenarzt; 1982 Feb; 53(2):67-71. PubMed ID: 7063089
[No Abstract] [Full Text] [Related]
6. Treatment of Parkinson's disease.
Lieberman A
Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):339-43. PubMed ID: 8507903
[TBL] [Abstract][Full Text] [Related]
7. Development of new pharmacological approaches in Parkinson's disease.
Carlsson A
Adv Neurol; 1987; 45():513-8. PubMed ID: 3493631
[No Abstract] [Full Text] [Related]
8. [Antiparkinsonian drugs (author's transl)].
Ando K
No To Shinkei; 1980 Aug; 32(8):743-53. PubMed ID: 7008813
[No Abstract] [Full Text] [Related]
9. Medications for Parkinson's disease.
Whitney CM
Neurologist; 2007 Nov; 13(6):387-8. PubMed ID: 18090719
[No Abstract] [Full Text] [Related]
10. Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists.
Kondo T
J Neurol; 2002 Sep; 249 Suppl 2():II25-9. PubMed ID: 12375060
[TBL] [Abstract][Full Text] [Related]
11. The history of dopamine and levodopa in the treatment of Parkinson's disease.
Fahn S
Mov Disord; 2008; 23 Suppl 3():S497-508. PubMed ID: 18781671
[TBL] [Abstract][Full Text] [Related]
12. [Drug therapy in Parkinson's disease].
van Hilten JJ; Roos RA
Ned Tijdschr Geneeskd; 1999 Jan; 143(5):234-40. PubMed ID: 10086151
[TBL] [Abstract][Full Text] [Related]
13. Levodopa in the treatment of Parkinson's disease: current controversies.
Olanow CW; Agid Y; Mizuno Y; Albanese A; Bonuccelli U; Damier P; De Yebenes J; Gershanik O; Guttman M; Grandas F; Hallett M; Hornykiewicz O; Jenner P; Katzenschlager R; Langston WJ; LeWitt P; Melamed E; Mena MA; Michel PP; Mytilineou C; Obeso JA; Poewe W; Quinn N; Raisman-Vozari R; Rajput AH; Rascol O; Sampaio C; Stocchi F
Mov Disord; 2004 Sep; 19(9):997-1005. PubMed ID: 15372588
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological basis of therapeutics: dopamine receptors.
Heikkila RE
J Med Soc N J; 1984 Dec; 81(12):1084-6. PubMed ID: 6150999
[No Abstract] [Full Text] [Related]
15. Physiology of the normal and dopamine-depleted basal ganglia: insights into levodopa pharmacotherapy.
Grace AA
Mov Disord; 2008; 23 Suppl 3():S560-9. PubMed ID: 18781673
[TBL] [Abstract][Full Text] [Related]
16. [L-threo-DOPS therapy and parkinsonism].
Narabayashi H
No To Shinkei; 1986 Jan; 38(1):60-2. PubMed ID: 3083844
[No Abstract] [Full Text] [Related]
17. Drug treatment of Parkinson's disease.
Callaghan N
Ir Med J; 1983 Aug; 76(8):364-6. PubMed ID: 6618850
[No Abstract] [Full Text] [Related]
18. Reevaluation of levodopa therapy for the treatment of advanced Parkinson's disease.
Yokochi M
Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S25-30. PubMed ID: 19131038
[TBL] [Abstract][Full Text] [Related]
19. [Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease].
Klivényi P; Vécsei L
Ideggyogy Sz; 2007 Jan; 60(1-2):61-4. PubMed ID: 17432097
[TBL] [Abstract][Full Text] [Related]
20. Are there clinically significant differences between dopamine agonists.
Stocchi F; Vacca L; Onofrj M
Adv Neurol; 2003; 91():259-66. PubMed ID: 12442684
[No Abstract] [Full Text] [Related]
[Next] [New Search]
